Jon P Stonehouse

CIK 1385496 · Chief Executive Officer · last filed 2026-06-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$11.87M

Companies

3

Total Filings

95

Lifetime Open-Market Net

-$9.34M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BCRX Chief Executive Officer 1,364,481 $8.70 $11.87M -$9.39M 77 2026-06-02
Metsera, Inc. (MTSR) Delisted Director 0 $70.50 $0 $0 2 2025-11-13
BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted Director 204,086 $0.07 $15.3K $45.6K 16 2023-01-05

Recent Filings · Page 5 of 10

95 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-12-06 BCRX Mixed -$633.6K EDGAR
2018-11-13 BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted Buy (P) +10,000 $45.6K EDGAR
2018-06-18 BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted Grant (A) $0 EDGAR
2018-05-21 BCRX Exer (M) +70,427 $100.0K EDGAR
2018-03-02 BCRX Mixed +13,725 -$29.2K EDGAR
2018-01-23 BCRX Tax (F) −9,584 -$53.6K EDGAR
2018-01-03 BCRX Tax (F) −2,716 -$13.3K EDGAR
2017-12-22 BCRX Grant (A) $0 EDGAR
2017-09-05 BCRX Grant (A) $0 EDGAR
2017-06-15 BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted Grant (A) $0 EDGAR
Showing 4150 of 95
Page 5 of 10
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.